Published • loading... • Updated
AngioDynamics, Inc. (ANGO) Stock Analysis: Potential 30% Upside Amid Strong Buy Ratings
Summary by DirectorsTalk Interviews
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
AngioDynamics, Inc. (ANGO) Stock Analysis: Potential 30% Upside Amid Strong Buy Ratings
AngioDynamics, Inc. (NASDAQ: ANGO) is garnering attention among healthcare investors as it stands poised for potential growth, driven by strategic advancements in medical technology. With a market capitalization of $635.28 million, this Latham, New York-based company is making significant strides in the medical instruments and supplies industry. Currently priced at $15.37 per share, AngioDynamics offers […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
